Sector: Pharmaceuticals & Biotechnology

Small Cap

Mangalam Drugs Share Price

Q: What is the current share price of Mangalam Drugs and Organics Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Mangalam Drugs and Organics Ltd. is ₹ 27.75 on the NSE and ₹ 28 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Mangalam Drugs and Organics Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Mangalam Drugs and Organics Ltd. is approximately ₹ 43.1 Cr.

Q: What are the PE and PB ratios for Mangalam Drugs and Organics Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Mangalam Drugs and Organics Ltd. is -1, and the Price-to-Book (PB) ratio is 0.4.

Q: What is the 52-Week High and Low for Mangalam Drugs and Organics Ltd.?

Over the past 52 weeks, the highest price reached by Mangalam Drugs and Organics Ltd. shares was ₹ 95, and the lowest price was ₹ 22.8.

Q: Who are the major shareholders of Mangalam Drugs and Organics Ltd.?

Significant shareholdings in Mangalam Drugs and Organics Ltd. typically include entities such as: Public Promoter FII Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Mangalam Drugs and Organics Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Mangalam Drugs and Organics Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Q: What is the latest dividend information for Mangalam Drugs and Organics Ltd.?

Mangalam Drugs and Organics Ltd. last declared a INTERIM dividend of ₹ 0.5 per share for the financial period ending 2017. The record date was set as 2017-12-21, and the payment was/is scheduled around 2017-12-21. For the most current dividend announcements, refer to official company filings.

MANGALAM

₹27.75

0.49(1.80%)

10th Jul 2026 | 3:28 PM

NSE : MANGALAM

Open Free Demat Account

Mangalam Drugs Performance

Price Movement

₹27.75

₹27.30

₹28.59

↘ Today's Low↗ Today's High

1 Year Performance

₹27.75

₹22.80

₹95.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹28.59

Low₹27.30

Open at₹27.99

Prev Close₹27.26

Volumes39.87 K

Avg Price₹27.88

Lower Circuit₹25.90

Upper Circuit₹28.62

Historical Performance

3M High₹31.49

3M Low₹26.63

1 Yr High₹95.00

1 Yr Low₹22.80

3 Yr High₹144.99

3 Yr Low₹22.80

5 Yr High₹196.95

5 Yr Low₹22.80

Summary

As of 10-07-2026 23:18, Mangalam Drugs and Organics Ltd. share price today is ₹0, with a change of ₹-27.26 (-100.00%) from the previous close of ₹27.26. The stock opened at ₹27.99 and traded between ₹27.3 and ₹28.59, with a total traded volume of 39870 shares. The company has a market capitalization of ₹43.1 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹95 and ₹22.8, respectively.

Mangalam Drugs and Organics Ltd. valuation metrics include a P/E ratio of -1, EPS of ₹-28.05, and book value of ₹0.40. Profitability indicators show ROE of -43.08%. Mangalam Drugs and Organics Ltd. has reported revenue of ₹232.67 Cr and net profit of ₹-44.4 Cr.

Mangalam Drugs and Organics Ltd. technical indicators include Day RSI at 34.53, Day MFI at 32.54, Day ADX at 31.54. Additional indicators include Commodity Channel Index (CCI) at -126.4 and Williams %R at -85.75. Momentum indicators show Day MACD at -0.46, Day MACD Signal Line at -0.28, DayATR at 1.34. Rate of Change indicators for Mangalam Drugs and Organics Ltd. include ROC125 at -10.09 and ROC21 at -3.78.

Exponential moving averages include EMA5 at ₹27.6, EMA10 at ₹28, EMA12 at ₹28.1, EMA20 at ₹28.4, EMA26 at ₹28.6, EMA50 at ₹29.1, EMA100 at ₹31.8, EMA200 at ₹41.2. Simple moving averages include SMA5 at ₹27.7, SMA10 at ₹28, SMA20 at ₹28.7, SMA30 at ₹28.6, SMA50 at ₹29.1, SMA100 at ₹29.8, SMA150 at ₹30.8, SMA200 at ₹39.3.

Support levels for Mangalam Drugs are placed at First Support ₹26.55, Second Support ₹25.84, Third Support ₹24.98. Resistance levels are seen at First Resistance ₹28.12, Second Resistance ₹28.98, Third Resistance ₹29.69. Mangalam Drugs and Organics Ltd. shareholding pattern shows promoter holding at 35.65%, FII holding at 0.32%, DII holding at 0%, public holding at 64.03%.

Mangalam Drugs Fundamentals

Market Cap

Low in industry

43.10 Cr.

PE Ratio (TTM)

Negative PE TTM

-1

Dividend Yield

Net Profit TTM

761% decr over last year

-44.40

Net Profit Growth

761% decr over last year

-44.40

PEG Ratio

Below industry Median

ROE

1055% decr over last year

-43.08

Operating Revenue TTM

232.67

Operating Revenue Growth

27% decr over last year

Book Value

Low in industry

0.40

MFI

MFI is mid-range

32.54

RSI

RSI is mid-range

34.53

EPS (TTM)

-28.05

Debt to Equity

1.02

Face Value

Operating Profit Margin Qtr.

-6.40

Operating Profit Qtr.

-5.62

Net Profit Qtr.

-13.42

Operating Revenue Qtr.

67.29

PB Ratio

0.40

Mangalam Drugs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	67.29	58.49	49.54	57.35	73.04
Operating Expense	72.64	59.96	52.38	61.85	62.88
Operating Profit	-5.36	-1.47	-2.83	-4.50	10.15
Depreciation	4.56	4.37	4.53	4.38	4.61
Interest	3.08	4.05	5.03	4.04	4.03
Tax	0.15	0	-5.12	0.80	1.58
Net Profit	-13.06	-9.78	-7.25	-13.73	0.15

Mangalam Drugs Technicals

Mangalam Drugs and Organics Ltd. EMA & SMA

₹27.75

0.82 (3.04%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹27.6

Day EMA10 ₹28

Day EMA12 ₹28.1

Day EMA20 ₹28.4

Day EMA26 ₹28.6

Day EMA50 ₹29.1

Day EMA100 ₹31.8

Day EMA200 ₹41.2

Mangalam Drugs Support and Resistance

Resistance

First Resistance₹28.12

Second Resistance₹28.98

Third Resistance₹29.69

Support

First Support₹26.55

Second Support₹25.84

Third Support₹24.98

Technical Indicators

Day RSI34.53

Day MFI32.54

Day ADX31.54

Day Commodity Channel Index-126.40

William-85.75

Day MACD-0.46

Day MACD Signal Line-0.28

Day ATR1.34

Day ROC125-10.09

Day ROC21-3.78

Mangalam Drugs Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	50.3	50.3	50.3	50.3	35.6	35.6
FII	0.1	0.5	0.5	0.1	0.1	0.3
DII	0	0	0	0	0	0
Public	49.6	49.2	49.2	49.6	64.2	64

Mangalam Drugs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	25.77 K	46.95 K	54.87%
Week	29.58 K	54.65 K	54.13%
1 Month	25.39 K	37.55 K	67.63%
6 Month	75.98 K	80.16 K	94.79%

Mangalam Drugs SWOT Analysis

Strengths6

Weakness12

Opportunity1

Threats1

PEG lower than Industry PEG

Increasing Revenue every quarter for the past 2 quarters

Companies with Zero Promoter Pledge

Companies with decreasing Promoter pledge

Stock with Low PE (PE < = 10)

Top Gainers

Mangalam Drugs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
21 Dec, 2017	0.5	INTERIM	22 Dec, 2017	Equity Share
19 Sep, 2006	0.2	FINAL		Equity Share
30 Aug, 2005	0.2	FINAL		Equity Share

Mangalam Drugs Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Valiant Laboratories Ltd.
Price (₹)	₹587.60	₹5.40	₹179.17	₹15.60	₹535	₹62
% Change	-1.43%	-0.18%	-2.00%	0.84%	-0.10%	-0.26%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	₹176.50	₹502.55	₹237.47
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	₹27.81	₹57.92	₹-3.28
PE TTM	-	-1.30	47.70	29.60	26.70	-103.00
1 Year Return	52.07	441	45.1	70	-25.38	-41.91
ROCE	3.56	-5.63	-	17.36	23.87	0.77

Similar Stocks

SIGACHI

Sigachi Industries Ltd.

₹ 22.67

+1.98%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+0.50%

VINEETLAB

Vineet Laboratories Ltd.

₹ 32.80

+0.43%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 568.90

+0.36%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.62

-1.99%

MEDICO

Medico Remedies Ltd.

₹ 39.10

+0.03%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 195.49

+1.38%

LASA

Lasa Supergenerics Ltd.

₹ 7.52

+1.21%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 330.00

+1.74%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 345.50

-1.31%

ORTINGLOBE

Ortin Global Ltd.

₹ 16.50

+1.10%

BROOKS

Brooks Laboratories Ltd.

₹ 69.90

-0.87%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2861.10

+7.69%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 204.61

+2.00%

ALPA

Alpa Laboratories Ltd.

₹ 68.70

+0.60%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 403.00

-0.99%

NECLIFE

Nectar Lifesciences Ltd.

₹ 11.21

-0.18%

INDOCO

Indoco Remedies Ltd.

₹ 259.00

+1.53%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 247.05

+4.87%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 612.00

+0.01%

PANACEABIO

Panacea Biotec Ltd.

₹ 546.00

-1.66%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 244.00

-0.57%

THEMISMED

Themis Medicare Ltd.

₹ 117.59

+1.33%

FAQ's on MANGALAM

What is the current share price of Mangalam Drugs and Organics Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Mangalam Drugs and Organics Ltd. is ₹ 27.75 on the NSE and ₹ 28 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Mangalam Drugs and Organics Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Mangalam Drugs and Organics Ltd. is approximately ₹ 43.1 Cr.

What are the PE and PB ratios for Mangalam Drugs and Organics Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Mangalam Drugs and Organics Ltd. is -1, and the Price-to-Book (PB) ratio is 0.4.

What is the 52-Week High and Low for Mangalam Drugs and Organics Ltd.?

Over the past 52 weeks, the highest price reached by Mangalam Drugs and Organics Ltd. shares was ₹ 95, and the lowest price was ₹ 22.8.

Who are the major shareholders of Mangalam Drugs and Organics Ltd.?

Significant shareholdings in Mangalam Drugs and Organics Ltd. typically include entities such as:

Public
Promoter
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Mangalam Drugs and Organics Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Mangalam Drugs and Organics Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Mangalam Drugs and Organics Ltd.?

Mangalam Drugs and Organics Ltd. last declared a INTERIM dividend of ₹ 0.5 per share for the financial period ending 2017. The record date was set as 2017-12-21, and the payment was/is scheduled around 2017-12-21. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy